Trump admin using AI to deny medical care for seniors in disastrous experiment | Vendors rolling out AI have an “incentive to deny as many claims as possible.”

AI systems used to deny medical care can be configured to prioritize claim denials, potentially impacting patient access to necessary treatments.

The Trump administration's pilot program, WISeR, which uses AI for prior authorization of certain Medicare services, has faced significant criticism and documented failures since its January rollout. Healthcare providers have reported technical difficulties, lengthy delays in decisions, and puzzling denials, leading to patient suffering and frustration. A report by the Electronic Frontier Foundation, based on federal documents obtained through litigation, confirmed these disastrous outcomes, with one provider calling the program "a disgrace to the human race." The Government Accountability Office also questioned the program's legality due to improper procedure in its setup. Vendors like Innovaccer and Zyter experienced implementation issues, with one vendor, Virtix, found to be denying more claims than approving and placed on a corrective action plan. Despite these problems, the program, designed to reduce fraud, waste, and abuse, appears slated for expansion.

The WISeR program's documented failures, including prolonged decision times and high denial rates, highlight the challenges of integrating AI into sensitive healthcare processes without robust oversight. The program's design, coupled with vendors' potential financial incentives to deny claims, raises serious ethical questions about prioritizing cost savings over patient well-being.

This situation underscores the need for greater transparency and accountability in the use of AI in healthcare, particularly for government-funded programs. Future implementations must prioritize patient outcomes, ensure adequate vendor vetting, and establish clear recourse for both patients and providers facing AI-driven administrative hurdles.